Computational Chemistry

At Anugraha Lifescience, we combine scientific expertise with computational power to bridge the gap between traditional and progressive drug discovery. Our Computational Chemistry services play a crucial role in accelerating both drug discovery and development.

Through advanced molecular modelling and simulation techniques, we empower our clients to design, predict, and optimize drug candidates with greater precision. By utilizing a range of methods, including protein binding site exploration, ligand-based screening, fragment-based drug discovery (FBDD), QSAR, e-ADME, and toxicity predictions, we refine and enhance compounds for maximum efficiency and safety.

Our approach enables faster lead identification, optimized molecular interactions, and data-driven insights, ultimately reducing development costs and mitigating R&D risks. By integrating these computational techniques early on, we reduce the need for extensive physical testing, allowing for targeted compound development while ensuring compliance with global regulatory standards.